Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)
Willem Pieter Brouwer(Erasmus MC), Krzysztof Simon(Wroclaw Medical University), Hendrik W. Reesink(Amsterdam University Medical Centers), Qing Xie(Shanghai Jiao Tong University), Ramazan Idılman(Ankara University), Bettina E. Hansen(Aarhus University), Harry L.A. Janssen(Erasmus MC), Adrian Streinu‐Cercel(Carol Davila University of Medicine and Pharmacy), Mircea Diculescu(Institutul Clinic Fundeni), Ning‐Ping Zhang(Fudan University), Elke Verhey(Erasmus MC), Fehmı Tabak(Istanbul University-Cerrahpaşa), Milan J. Sonneveld(Erasmus MC), Jurriën G.P. Reijnders(Erasmus MC), Włodzimierz Mazur(Medical University of Silesia), Qin Zhang(Novartis (Switzerland)), Jiyao Wang(Fudan University), Meral Akdoğan(Türkiye Yüksek İhtisas Hastanesi), M Voiculescu(Genfit (France))
Cited by 165
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
|Hepatology|2017|657
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis
|JAMA Dermatology|2019|505
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
|Journal of Viral Hepatitis|2014|484